Biotechnology VALUE FUND L P, 10% Owner at FIVE PRIME THERAPEUTICS, INC. (FPRX), bought 2,240,020 shares at $3.40 ($7.6M) on 2019-11-22, disclosed to the SEC on 2019-11-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.40 | 81,857 | $278K | 3.7% |
| 2 | $3.40 | 81,857 | $278K | 3.7% |
| 3 | $3.40 | 462,056 | $1.6M | 20.6% |
| 4 | $3.40 | 462,056 | $1.6M | 20.6% |
| 5 | $3.40 | 576,097 | $2.0M | 25.7% |
| 6 | $3.40 | 576,097 |
| $2.0M |
| 25.7% |
| Total | $3.40 avg | 2,240,020 | $7.6M | 100% |
| Filing → |
| KYMR | BUY | 2022-05-24 | $141K | — | Filing → |
| OLMA | BUY | 2021-12-02 | $13.9M | — | Filing → |
| KYMR | BUY | 2021-07-06 | $25.6M | — | Filing → |